Seeking Strategic Development and Licensing Partners.
Islet Sciences is actively seeking partners who want to build differentiated pharmaceutical products on the biphasic drug delivery platform — across therapeutic categories, compound classes, and global markets.
Who we're looking for.
Drug Developers
Programs seeking a differentiated delivery architecture for an existing or pipeline molecule.
Generic Manufacturers
Companies pursuing branded-quality differentiation beyond commodity generic positioning.
Value-Added Generic Companies
Reformulation specialists building premium, IP-protected products from established molecules.
Specialty Pharma
Focused therapeutic-area players pursuing lifecycle and combination-product opportunities.
Drug Delivery Companies
Complementary delivery platforms exploring co-development or in-licensing.
Global Pharmaceutical Companies
Worldwide developers and commercial organizations pursuing 505(b)(2) differentiation strategies.
Flexible licensing structures.
The platform is fundamentally multi-product. We are open to structures that match the strategic intent of the partner — from single-compound licenses through full worldwide platform access.